Press Releases Home - Investor Relations - Press Releases Press Releases Year None2023202220212020201920182017201620152014 Date Title March 28, 2023 Corcept Therapeutics Initiates CATALYST Clinical Trial March 6, 2023 Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock February 28, 2023 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update February 14, 2023 Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call February 13, 2023 Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation Shareholder Tools Email Alerts Print Page RSS Feeds
Press Releases Year None2023202220212020201920182017201620152014 Date Title March 28, 2023 Corcept Therapeutics Initiates CATALYST Clinical Trial March 6, 2023 Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock February 28, 2023 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update February 14, 2023 Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call February 13, 2023 Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation
